Future studies have to investigate whether PD-L1 copy number status, which is stable in the primary tumor and corresponding lymph node metastasis, might be a better predictive marker for tumor response to blockage of PD-1/PD-L1 pathway [34] than PD-L1 immunohistochemical status. Here, CD274 is linked to neoplasm.